Short Communication
Volume 12 Issue 5 - 2020
The Star Studded Protein and its Chaperone Mediated Pathways: Faulty Lysosomal-Autophagic System, Alpha-Synuclein Aggregates in Parkinson’s Disease and its Relevance to Therapeutic Intervention
Jeswinder Sian-Hulsmann*
Department of Medical Physiology, University of Nairobi, Kenya
*Corresponding Author: Jeswinder Sian-Hulsmann, Department of Medical Physiology, University of Nairobi, Kenya.
Received: March 05, 2020; Published: April 30, 2020




Plethora of research findings over recent years have led to the elevation of α-synuclein to star status in the etiology of PD. Rogue pathogenic proteins such as α-synuclein, appear to play a malevolent role in the development of Parkinson’s disease(PD) and other α-synucleinopathies. They share a common denominator, which is characterised by aggregates of misfolded α-synuclein, which results in the formation of intra-neuronal inclusions known as Lewy bodies (LB). The presence of LB in substantia nigra is mandatory for the neuropathological diagnosis of PD. Interestingly, the occurrence of these structures appear to mirror areas exhibiting neuronal cell loss such as the substantia nigra pars compacta and other brain areas burdened with the onslaught of the disease, thereby suggesting that they are of focal relevance to the disorder. Furthermore, the presence of LB in the asymptomatic phase of PD (incidental Lewy body disease; [1] endorses their role in the pathogenesis. It is unclear whether they represent a cause or consequence of the illness. Therefore, in order to advocate effective therapeutic intervention it is imperative to elucidate the pathways or mechanism(s) underlying disruption of protein homeostasis, α-synuclein accumulation LB formation.

References

  1. Gibb WR and Lees AJ. “The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease”. Neuropathology and Applied Neurobiology 15.1 (1989): 27-44.
  2. Brown DR. “α-Synuclein as a ferrireductase”. Biochemical Society Transactions 41.6 (2013): 1513-1517. 
  3. Blesa J., et al. “Oxidative stress and Parkinson’s disease”. Frontiers in Neuroanatomy 9 (2015): 91.
  4. Sian J., et al. “Decrease in nigral reduced glutathione in Parkinson’s Disease”. British Journal of Pharmacology 104 (1991): 281.
  5. Zhuang XX., et al. “Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson’s disease models”. Cell Death and Disease 11 (2020): 128.
  6. Xilouri M., et al. “α-Synuclein and protein degradation systems: a reciprocal relationship”. Molecular Neurobiology 47.2 (2013): 537-551. 
  7. Lehtonen S., et al. “Dysfunction of Cellular Proteostasis in Parkinson’s Disease”. Frontiers in Neuroscience 13 (2019): 457.
  8. Darius Ebrahimi-Fakhari. “Protein degradation pathways in Parkinson's disease: Curse or blessing”. Acta Neuropathologica 124.2 (2012): 153-157.
  9. Lee JH., et al. “Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes”. Acta Neuropathologica Communications 7.1 (2019): 68.
  10. Arotcarena ML., et al. “Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery”. Cells 8.6 (2019): E565.
  11. Mak SK., et al. “Lysosomal degradation of alpha-synuclein in vivo”. Journal of Biological Chemistry 285.18 (2010): 13621-13629.
  12. Mazzulli JR., et al. “α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models”. Proceedings of the National Academy of Sciences of the United States of America 113.7 (2016): 1931-1936.
  13. Campbell P., et al. “Chaperone-mediated autophagy as a therapeutic target for Parkinson disease”. Expert Opinion on Therapeutic Targets 22.10 (2018): 823-832.
  14. Mullin S., et al. “Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial”. JAMA Neurology (2020): 4611. 
  15. Narita A., et al. “Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study”. Annals of Clinical and Translational Neurology 3.3 (2016): 200-215.
  16. Wallings RL., et al. “Lysosomal dysfunction at the centre of Parkinson’s disease and frontotemporal dementia/amyotrophic lateral sclerosis”. Trends in Neuroscience 42.12 (2019): 899-912.
  17. Martinez A., et al. “Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease”. Biology of the Cell 111.6 (2019): 161-168.
Citation: Jeswinder Sian-Hulsmann. “The Star Studded Protein and its Chaperone Mediated Pathways: Faulty Lysosomal-Autophagic System, Alpha-Synuclein Aggregates in Parkinson’s Disease and its Relevance to Therapeutic Intervention”. EC Neurology 12.5 (2020): 46-49.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk